PMC:7534795 / 30297-30489
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T244","span":{"begin":107,"end":117},"obj":"Disease"},{"id":"T245","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A244","pred":"mondo_id","subj":"T244","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"},{"id":"A245","pred":"mondo_id","subj":"T245","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"These findings, consequently, reinforced the recommendation to use antiplatelets and other pharmacological thrombosis prophylaxis drugs in all COVID-19 patients (Klok et al., 2020) (Table 4 )."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T224","span":{"begin":130,"end":135},"obj":"Chemical"}],"attributes":[{"id":"A224","pred":"chebi_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"These findings, consequently, reinforced the recommendation to use antiplatelets and other pharmacological thrombosis prophylaxis drugs in all COVID-19 patients (Klok et al., 2020) (Table 4 )."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T210","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These findings, consequently, reinforced the recommendation to use antiplatelets and other pharmacological thrombosis prophylaxis drugs in all COVID-19 patients (Klok et al., 2020) (Table 4 )."}
2_test
{"project":"2_test","denotations":[{"id":"33031856-32291094-84038871","span":{"begin":175,"end":179},"obj":"32291094"}],"text":"These findings, consequently, reinforced the recommendation to use antiplatelets and other pharmacological thrombosis prophylaxis drugs in all COVID-19 patients (Klok et al., 2020) (Table 4 )."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1034","span":{"begin":152,"end":160},"obj":"Species"},{"id":"1050","span":{"begin":107,"end":117},"obj":"Disease"},{"id":"1051","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A1034","pred":"tao:has_database_id","subj":"1034","obj":"Tax:9606"},{"id":"A1050","pred":"tao:has_database_id","subj":"1050","obj":"MESH:D013927"},{"id":"A1051","pred":"tao:has_database_id","subj":"1051","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"These findings, consequently, reinforced the recommendation to use antiplatelets and other pharmacological thrombosis prophylaxis drugs in all COVID-19 patients (Klok et al., 2020) (Table 4 )."}